Good news! This was in my email from Medscape today
Says, in part...
"The study was published
in the July 4 issue of JAMA
The results may help allay fears that the live-attenuated HZ virus in the vaccine (Zostavax
, Merck) may cause a varicella outbreak in people treated with immunosuppressives to control immune-mediated diseases such as rheumatoid arthritis (RA). However, those diseases also leave people more vulnerable to a shingles outbreak, with approximately twice the risk for HZ than the general population. The US Food & Drug Administration, the Advisory Committee on Immunization Practices, and the American College of Rheumatology contraindicate the vaccine for patients receiving the immunosuppressives.
Jie Zhang, PhD, biostatistician, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, and colleagues examined the Medicare claims data from 2006 to 2009 of 463,541 people, including 18,683 individuals who were vaccinated for HZ. All patients were aged 60 years and older and diagnosed with RA, psoriasis, psoriatic arthritis, ankylosing spondylitis, or inflammatory bowel disease."
[To view the link, you do need to have a free registration with Medscape.] http://www.medscape.com/viewarticle/766842?sssdmh=dm1.799964&src=nldne